StonvexLoading…
StonvexStonvexStonvexCore line items from LOB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $908.47M | $812.37M | $688.27M | $444.47M |
Operating Income | $142.81M | $89.23M | $82.83M | $210.32M |
Net Income | $105.87M | $77.47M | $73.90M | $176.21M |
EPS (Diluted) | $2.23 | $1.69 | $1.64 | $3.92 |
Total Assets | $15.13B | $12.94B | $11.27B | $9.86B |
Total Liabilities | $13.88B | $11.94B | $10.37B | $9.04B |
Cash & Equivalents | $864.90M | $608.80M | $582.54M | $416.64M |
Free Cash Flow OCF − CapEx | $143.49M | $107.47M | $138.06M | $-344.50M |
Shares Outstanding | 46.04M | 45.82M | 45.09M | 44.91M |